Otsuka Pharmaceutical Co., Ltd.

Pharmaceuticals
November 21, 2011

Streptococcus pneumoniae Kit “RAPIRUN S. pneumoniae HS (otitis media/sinusitis)” as in vitro diagnostic releases on December 1

Otsuka Pharmaceutical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) today announced the launch of "RAPIRUN S. pneumoniae HS (otitis media/sinusitis)", Streptococcus pneumoniae antigen detection reagent by the immunochromatographic method, as an in vitro diagnostic on December 1, 2011.